Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system

Antimicrob Agents Chemother. 2010 May;54(5):2235-8. doi: 10.1128/AAC.01665-09. Epub 2010 Mar 8.

Abstract

A phenotypic and genotypic analysis of Acinetobacter baumannii was conducted from 2003 to 2008 in Detroit, MI. The incidence of A. baumannii increased from 1.7 to 3.7/1,000 patient days during the study period. Susceptibility to ampicillin-sulbactam and imipenem decreased from approximately 90% to approximately 40%. Genotyping revealed polyclonality, suggesting either emergence of multiple resistant strains or spread of a common genetic element. The sharp rise mandates major multidisciplinary interventions to optimize management of this multidrug-resistant pathogen.

MeSH terms

  • Academic Medical Centers / statistics & numerical data
  • Acinetobacter Infections / drug therapy*
  • Acinetobacter Infections / epidemiology*
  • Acinetobacter Infections / microbiology
  • Acinetobacter baumannii / drug effects*
  • Acinetobacter baumannii / genetics
  • Ampicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Drug Resistance, Bacterial / genetics*
  • Genotype
  • Humans
  • Imipenem / therapeutic use
  • Michigan / epidemiology
  • Phylogeny
  • Prevalence
  • Retrospective Studies
  • Sulbactam / therapeutic use
  • Urban Population / statistics & numerical data

Substances

  • Anti-Bacterial Agents
  • sultamicillin
  • Imipenem
  • Ampicillin
  • Sulbactam